Menopause

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

The 2022 position statement confirms hormone therapy as the most effective treatment for vasomotor symptoms in menopause and includes updated guidelines for age- and condition-specific treatment plans.

New research from a team of investigators in Europe suggests hormonal changes during menopause could explain up to 10% of the increase in LDL-C associated with the transition to menopause among aging women

Vaginal estradiol tablets produced significant changes in vaginal microbiota and metabolome with a lowering pH, especially in women with highly divers bacterial communities at baseline, according to a secondary analysis in JAMA Network Open.

A Canadian study published in the journal Menopause found a significant link between rotating shift work and delayed onset of menopause.

Women with laparoscopically confirmed endometriosis are at significantly higher risk for early natural menopause (ENM), and this risk was greater for nulliparous women and women who never reported using oral contraceptives, according to a study in JAMA Network Open.

New research from the University of California Los Angeles (UCLA) suggests assessments of anti-Mullerian hormone levels could help clinicians predict or detect bone loss among premenopausal women.

Bilateral oophorectomy is associated with an increased risk of dementia, according to findings from a prospective cohort study in the journal Menopause.

A study published in Menopause, the journal of the North American Menopause Society (NAMS), investigated the association between sleep apnea and the various physical and psychological symptoms that occur during menopause.

A recent study found overweight status in midlife, compared to normal body mass index, was linked to a higher burden of morbidity and greater proportion of life lived with morbidity.

Astellas announced positive data from its study investigating the long-term safety of fezolinetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

More than half of postmenopausal women experience female pattern hair loss, according to a cross-sectional study in the journal Menopause.

Risk assessment, lifestyle counseling, adverse effects, and medication management.

Women with severe menopausal symptoms are likely to experience significantly greater cognitive decline than their counterparts with mild menopausal symptoms, according to a cross-sectional study in the journal Menopause.

New study results suggest that severe depression and sexual dysfunction, in particular, can affect a woman's attention, language, orientation, recall, registration, and visuospatial skills.

Being Non-Hispanic (N-H) Asian is a significant influencing factor for the number of gastrointestinal (GI) symptoms and the severity scores of GI symptoms, according to a study of 4 major racial/ethnic groups of midlife women in the United States.

According to a recent study, women who experience stable menstrual cycles during the menopause transition have a significantly higher cardiovascular disease (CVD) risk later in life than those who have a late increase in cycle length.

A study in JAMA Network Open has concluded that women who undergo bilateral oophorectomy before menopause are significantly more likely to develop mild cognitive impairment and poorer performance on cognitive tests about 30 years later compared to women who do not have the procedure.

Certain post-menopausal women with HR-positive, HER2-negative breast cancer may be able to only undergo endocrine therapy after surgery – sparing themselves from the chemotherapy side effects.

For women with postmenopausal vaginal symptoms, fractional carbon dioxide laser versus sham treatment fails to significantly improve vaginal symptoms after 12 months, according to the results of a randomized controlled trial in JAMA.

Vasomotor symptoms (VMS) are significantly less common in menopausal women with sarcopenia than in those without, according to a study conducted in the Republic of Korea.

Midlife women with early-stage vision impairment are significantly more likely to develop depressive symptoms, according to a study in the journal Menopause, which used data from the Michigan site of the Study of Women’s Health Across the Nation (SWAN).

Margo B. Minissian, PhD, shares key updates from the newest recommendations for primary prevention of cardiovascular disease in women from the ACC and AHA. Minissian is executive director, Geri & Richard Brawerman Nursing Institute at Cedars-Sinai Medical Center and the Simms/ Mann Endowed Chair of Nursing Education, Innovation and Research at Cedars-Sinai Medical Center.

Past president Sheryl Kingsberg, PhD, discusses the paper she chose to present as paper of the year at NAMS 2021.

We caught up with Risa Kagan, MD, at the North American Menopause Society's 2021 Annual Meeting to hear about her role on the Scientific Planning Committee and this year's takeaways.